PYXS

Pyxis Oncology, Inc.

• TipRanks·2d ago

  RBC Capital Remains a Buy on Pyxis Oncology (PYXS)

• Seeking Alpha·10/04 13:30

  Pyxis Oncology: Better Runway Is Bullish For MICVO's Remaining R&D

• TipRanks·10/01 10:40

  Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Pyxis Oncology (PYXS)

• Benzinga·09/30 17:06

  12 Health Care Stocks Moving In Wednesday's Intraday Session

• Benzinga·09/30 12:05

  12 Health Care Stocks Moving In Wednesday's Pre-Market Session

• TipRanks·09/30 11:06

  Pyxis Oncology 36M share Spot Secondary priced at $2.90

• NASDAQ·09/30 10:09

  Pyxis Prices $110 Mln Offering, With Potential Proceeds Of $282 Mln To Advance Lead Cancer Drug

• Seeking Alpha·09/30 09:08

  Biggest stock movers Wednesday: BA, PYXS, NOC, and more

• Seeking Alpha·09/30 06:16

  Pyxis Oncology shares slide after pricing $110M registered public offering

• TipRanks·09/29 23:30

  Closing Bell Movers: Boeing up on new fighter jet contract

• Seeking Alpha·09/29 20:42

  Pyxis Oncology launches offering for phase 3 cancer trial; stock tumbles

• TipRanks·09/29 20:30

  Pyxis Oncology announces common stock offering, no amount given

• Benzinga·09/29 20:25

  Pyxis Oncology Launches Public Offering Of Common Stock/Pre-Funded Warrants And Warrants To Fund MICVO Phase 3 Development; No Terms Disclosed

• Benzinga·09/29 20:24

  Pyxis Oncology Terminates $150M ATM Offering, Says As Of The Date Of This Supplement, We Have Not Sold Any Shares Of Our Common Stock Pursuant To The Sales Agreement

• TipRanks·09/26 14:35

  LifeSci Capital Remains a Buy on Pyxis Oncology (PYXS)